Managing the risks posed by hazardous chemicals in a pharmaceutical company

Type of item
MS information
Country
Lotyšsko
Year of publication
2018

English

Description

The Latvian pharmaceutical company on which this case study focuses found that involving workers in the identification of occupational safety and health problems — and indeed in all stages of an intervention to improve safety and health — is crucial for implementing effective prevention measures. The company implemented measures to significantly reduce or eliminate exposures to carcinogens, mutagens, reprotoxic substances and other hazardous chemicals among its workers, in particular pregnant and breastfeeding workers.

Other data

Tasks covered
Handling Chemicals
Processing Materials
Biological hazard
Not applicable
Hazard - physical state
Aerosols
Dusts
Liquids
Hazard - health effects
Allergens
Skin sensitisers
Asphyxiants
Carcinogens
Neurotoxic substances
Exposure route
Dermal contact
Inhalation
Substance Description

Fluorouracil (active pharmaceutical ingredient)

CAS Number
51-21-8
EC number
200-085-6
Prevention measures
Level 1. Elimination of hazards
Level 2. Technical measures, e.g. local exhaust ventilation
Level 2. Reducing / minimising the risk by organisational measures, e.g. reducing the number of workers exposed
Level 3. Reducing / minimising the risk by personal measures (PPE)
Training / guidance
Hygiene measures
Purpose of the material
Awareness raising
Guidance
Other
Target group
Employers
Managers
OSH consultant
Safety officers
Supervisor
Trainers
Workers representatives